1) malignant hematologic diseases
恶性血液疾病
1.
Objective To evaluate the efficacy of hematopoietic stem cell transplantation with fractionated total body irradiation(fTBI) based preparation regimen in patients with malignant hematologic diseases.
目的研究标准分次全身放疗(fTB I)预处理方案对自体、异体造血干细胞移植治疗恶性血液疾病疗效的影响。
3) Refractory hematologic malignancies
难治性恶性血液疾病
4) hematological malignance
恶性血液系统疾病
1.
【Objective】To investigate the effect of anti-hematological malignances and its mechanisms of extracts from Marsdenia tenacissima(trade name:Xiao aiping),and the effect of extracts from Marsdenia tenacissima on normal human immunocytes and hemopoietic stem cells(HSCs).
【目的】探讨通关藤提取物(商品名:消癌平)抗恶性血液系统疾病作用及机制,以及通关藤提取物对正常免疫细胞及造血干细胞功能的影响。
5) Hematological malignancies
恶性血液病
1.
Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies;
47例恶性血液病患者侵袭性真菌感染的临床特点与治疗
2.
Analysis of bacterial distribution and drug resistance in nasal infection among patients with hematological malignancies;
恶性血液病患者鼻部感染的病原菌分布及耐药性分析
6) hematologic malignancies
恶性血液病
1.
Long-term efficacy of Cy-VP16-fTBI conditioning regimen in hematopoietic stem cell transplantation for hematologic malignancies;
Cy-VP16-fTBI预处理的干细胞移植治疗恶性血液病的长期疗效
2.
A survey on life quality of patients with hematologic malignancies and its influential factors;
恶性血液病住院病人生活质量及其影响因素的调查研究
3.
Clinical observation of peripheral blood stem cell transplantation for treatment of hematologic malignancies and solid tumors;
外周血干细胞移植治疗恶性血液病及实体瘤的临床观察
补充资料：血液和造血系统疾病
血液和造血系统疾病
通常简称为"血液病"。原发于造血系统和主要累及于造血系统的疾病。常反映在血细胞成分质和量的改变，和/或凝血机制的障碍。包括各类贫血、红细胞增多症、白血病、淋巴瘤、骨髓瘤、白细胞减少及各类出血性疾病等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条